In a Series A fundraising round headed by Vertex Ventures, Spyne, an AI-powered visual marketing platform for the automobile ...

AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...

Latigo Biotherapeutics, a non-opioid pain biotech looking to ride the waves created by Vertex Pharmaceuticals' pain drug ...

This investment will fuel Spyne's growth trajectory, focusing on aggressive expansion in the US and developing its ...

In documents and videos seen by Semafor, The Times outlined how staffers should and shouldn't use artificial intelligence. For example, employees are encouraged to use tools ...

The Parnassus Growth Equity Fund returned 4.85% (net) for Q4 2024, underperforming the Russell 1000 Growth Index’s 7.07%.

The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

According to reports, OpenAI, the startup that created ChatGPT, is in talks to build data centers in India. Business Standard ...

Bryan Johnson is ready to live forever, and he wants others to do the same.

Healthcare isn't the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months, healthcare ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...